Spots Global Cancer Trial Database for A Chart Review Study of Adults With Advanced NSCLC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Chart Review Study of Adults With Advanced NSCLC
Official Title: Patterns of Care and Clinical Outcomes of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
Study ID: NCT05207423
Conditions
Interventions
Study Description
Brief Summary: The main aim is to see how treatment patterns and drugs might improve care for adults with advanced or metastatic NSCLC with epidermal growth factor receptor (EGFR) exon-20 driven mutations. Past medical records will be reviewed. No clinic visits or procedures will be required.
Detailed Description: This is a retrospective, observational study in participants with advanced NSCLC with EGFR exon-20 driven mutations. This study will look at clinical outcomes, patterns of care and disease management strategies and healthcare resource utilization (HCRU) in a routine clinical practice setting in the real world. The study will enroll approximately 218 participants. Participants who were treated at the participating sites between 01 January 2017 and 30 November 2021 will be included. The data will be collected retrospectively at the specialized centers from the participants medical records and notes. All the participants will be assigned to a single observational cohort: ⢠Participants With Advanced NSCLC With EGFR Exon-20 Mutations This multi-center study will be conducted in Canada, France and Hong Kong. The overall duration of the study will be 6 months.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
William Osler Health System, Brampton, Ontario, Canada
Grand River Hospital, Kitchener, Ontario, Canada
Ottawa Hospital Research Institute., Ottawa, Ontario, Canada
University Health Network Princess Margaret Cancer Research Tower (PMCRT) The MaRS Centre, East Tower, Toronto, Ontario, Canada
Centre Hospitalier de Saint-Quentin, Saint-Quentin cedex, Aisne, France
Hopital Nord - CHU Marseille, Marseille, Bouches-du-Rhone, France
Centre Francois Baclesse, Caen Cedex 05, Calvados, France
Centre Georges Francois Leclerc, Dijon Cedex, Cote-d'Or, France
CHU Brest - Hopital Morvan, Brest Cedex, Finistere, France
Institut Bergonie, Bordeaux cedex, Gironde, France
Hopital Larrey, Toulouse, Haute Garonne, France
Centre Hospitalier de la Region d'Annecy, Pringy cedex, Haute Savoie, France
Hopital Albert Calmette - CHU Lille, Lille Cedex, Nord, France
Institut Curie - site de Paris, Paris Cedex 05, Paris, France
CHU Clermont-Ferrand, Clermont Ferrand cedex, Puy De Dome, France
Centre Leon Berard, Lyon, Rhone, France
Hospices Civils de Lyon, Lyon, Rhone, France
CHU Strasbourg - Nouvel Hopital Civil, Strasbourg, Rhone, France
Centre Hospitalier Regional de la Reunion, Saint-Pierre, Seine Saint Denis, France
Hospital Center Henri Duffaut, Avignon, Vaculuse, France
Centre Hospitalier Intercommunal de Creteil, Creteil Cedex, Val De Marne, France
CHU Poitiers - Hopital la Miletrie, Poitiers, Vienne, France
Hopital de Versailles, Versailles, Yvelines, France
Hopital Tenon, Paris, , France
Pamela Youde Nethersole Eastern Hospital, Hong Kong, , Hong Kong
Prince of Wales Hospital, Hong Kong, , Hong Kong
Princess Margaret Hospital, Hong Kong, , Hong Kong
Queen Elizabeth Hospital, Hong Kong, , Hong Kong
Queen Mary Hospital, Hong Kong, , Hong Kong
Tuen Mun Hospital, Hong Kong, , Hong Kong
Contact Details
Name: Study Director
Affiliation: Takeda
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
